Harald Mudra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Harald Mudra has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
Jochen Senges
Institute for Myocardial Infarction Research Foundation, Ludwigshafen, Germany
3 shared publications- Ralf Zahn
Medizinische Klinik B, Klinikum der Stadt Ludwigshafen am Rhein Gemeinnützige GmbH, Heart Centre Ludwigshafen, Ludwigshafen, Germany
3 shared publications Christoph H. Spes
Klinik für Kardiologie, Pneumologie und Internistische Intensivmedizin
2 shared publicationsRalph Hein
2 shared publicationsA. Linke
Universität Leipzig
1 shared publicationAndreas Binder
Department of Neurology, UKSH Campus Kiel, Kiel, Germany
1 shared publication
Latest Publications
- Top Cited Papers
- 14 September 2022
- Published by Elsevier in The Lancet Neurology
- Vol. 21 (10) , 877-888
Carotid endarterectomy or stenting or best medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis: 5-year results of a multicentre, randomised controlled trial
- 14 September 2022
- Published by Elsevier in The Lancet Neurology
- Vol. 21 (10) , 877-888
Top Cited PapersCarotid endarterectomy or stenting or best medical treatment alone for moderate-to-severe asymptomatic carotid artery stenosis: 5-year results of a multicentre, randomised controlled trial
- Open Access
- 9 November 2021
- Published by Springer Nature in Herz
- Vol. 47 (6) , 543-552
Survey of clinical practice pattern in Germany’s certified chest pain units
Background: We aimed to analyze the 2020 standard of care in certified German chest pain units (CPU) with a special focus on non-ST-segment elevation acute coronary syndrome (NSTE-ACS) through a voluntary survey obtained from all certified units, using a prespecified questionnaire. Methods: The assessment included the collection of information on diagnostic protocols, risk assessment, management and treatment strategies in suspected NSTE-ACS, the timing of invasive therapy in non-ST-segment elevation myocardial infarction (NSTEMI), and the choice of antiplatelet therapy. Results: The response rate was 75%. Among all CPUs, 77% are currently using the European Society of Cardiology (ESC) 0/3‑h high-sensitive troponin protocol, and only 20% use the ESC 0/1‑h high-sensitive troponin protocol as a default strategy. Conventional ergometry is still the commonly performed stress test with a utilization rate of 47%. Among NSTEMI patients, coronary angiography is planned within 24 h in 96% of all CPUs, irrespective of the day of the week. Prasugrel is the P2Y12 inhibitor of choice in ST-segment elevation myocardial infarction (STEMI), but despite the impact of the ISAR-REACT 5 trial on selection of antiplatelet therapy, ticagrelor is still favored over prasugrel in NSTE-ACS. If triple therapy is used in NSTE-ACS with atrial fibrillation, it is maintained up to 4 weeks in 51% of these patients. Conclusion: This survey provides evidence that Germany’s certified CPUs ensure a high level of guideline adherence and quality of care. The survey also identified areas in need of improvement such as the high utilization rate of stress electrocardiogram (ECG).
- 9 November 2021
- Published by Springer Nature in Herz
- Vol. 47 (6) , 543-552
Open AccessSurvey of clinical practice pattern in Germany’s certified chest pain units
Background: We aimed to analyze the 2020 standard of care in certified German chest pain units (CPU) with a special focus on non-ST-segment elevation acute coronary syndrome (NSTE-ACS) through a voluntary survey obtained from all certified units, using a prespecified questionnaire. Methods: The assessment included the collection of information on diagnostic protocols, risk assessment, management and treatment strategies in suspected NSTE-ACS, the timing of invasive therapy in non-ST-segment elevation myocardial infarction (NSTEMI), and the choice of antiplatelet therapy. Results: The response rate was 75%. Among all CPUs, 77% are currently using the European Society of Cardiology (ESC) 0/3‑h high-sensitive troponin protocol, and only 20% use the ESC 0/1‑h high-sensitive troponin protocol as a default strategy. Conventional ergometry is still the commonly performed stress test with a utilization rate of 47%. Among NSTEMI patients, coronary angiography is planned within 24 h in 96% of all CPUs, irrespective of the day of the week. Prasugrel is the P2Y12 inhibitor of choice in ST-segment elevation myocardial infarction (STEMI), but despite the impact of the ISAR-REACT 5 trial on selection of antiplatelet therapy, ticagrelor is still favored over prasugrel in NSTE-ACS. If triple therapy is used in NSTE-ACS with atrial fibrillation, it is maintained up to 4 weeks in 51% of these patients. Conclusion: This survey provides evidence that Germany’s certified CPUs ensure a high level of guideline adherence and quality of care. The survey also identified areas in need of improvement such as the high utilization rate of stress electrocardiogram (ECG).
- 20 February 2015
- Published by Springer Nature in Der Kardiologe
- Vol. 9 (1) , 89-123
Leitlinie zum Einrichten und Betreiben von Herzkatheterlaboren und Hybridoperationssälen/Hybridlaboren
- 20 February 2015
- Published by Springer Nature in Der Kardiologe
- Vol. 9 (1) , 89-123
Leitlinie zum Einrichten und Betreiben von Herzkatheterlaboren und Hybridoperationssälen/Hybridlaboren
- 1 September 2014
- Published by PCR Digital & Publishing in EuroIntervention
- Vol. 10 (5) , 602-608
Transcatheter aortic valve implantation (TAVI) by centres with and without an on-site cardiac surgery programme: preliminary experience from the German TAVI registry
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 1 September 2014
- Published by PCR Digital & Publishing in EuroIntervention
- Vol. 10 (5) , 602-608
Transcatheter aortic valve implantation (TAVI) by centres with and without an on-site cardiac surgery programme: preliminary experience from the German TAVI registry
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 1 September 2009
- Published by Elsevier in The American Journal of Cardiology
- Vol. 104 (5) , 725-731
Effectiveness and Safety of Carotid Artery Stenting for Significant Carotid Stenosis in Patients With Contralateral Occlusion (from the German ALKK-CAS Registry Experience)
- 1 September 2009
- Published by Elsevier in The American Journal of Cardiology
- Vol. 104 (5) , 725-731
Effectiveness and Safety of Carotid Artery Stenting for Significant Carotid Stenosis in Patients With Contralateral Occlusion (from the German ALKK-CAS Registry Experience)
- 17 August 2007
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 96 (11) , 812-821
Short- and long-term outcome after carotid artery stenting with neuroprotection: single-center experience within a prospective registry
Carotid artery stenting is an alternative method to surgical endarterectomy for treatment of carotid artery stenosis.
- 17 August 2007
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 96 (11) , 812-821
Short- and long-term outcome after carotid artery stenting with neuroprotection: single-center experience within a prospective registry
Carotid artery stenting is an alternative method to surgical endarterectomy for treatment of carotid artery stenosis.
- 1 January 1997
- Published by Elsevier in American Heart Journal
- Vol. 133 (1) , 29-35
Coronary plaque morphologic characteristics early and late after heart transplantation: In vivo analysis with intravascular ultrasonography
- 1 January 1997
- Published by Elsevier in American Heart Journal
- Vol. 133 (1) , 29-35
Coronary plaque morphologic characteristics early and late after heart transplantation: In vivo analysis with intravascular ultrasonography